The 2002 Guidelines stated that neostigmine is effective for antagonizing the residual effect of muscle relaxants Evidence A1-B, although it showed increasing number of postoperative emetic episodes Evidence A1-H.
La Guía 2002indicaba que la neostigmina es efectiva para antagonizar el efecto residual de los relajantes musculares evidencia A1-B, aunque demostraba un aumento de los episodios de emesis postoperatoria evidencia A1-H.